Dr. Helen Su, a clinical immunologist who has made key discoveries into the genetic causes of rare immune system diseases in children, has been awarded the fourth annual Gale and Ira Drukier Prize in Children’s Health Research.
Dr. Manuel Hidalgo, a leading physician-scientist who specializes in pancreatic cancer and drug development, has been named chief of the Division of Hematology and Medical Oncology in the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective June 1.
On the heels of the civil rights movement, a small, Ivy League medical school in New York City, long committed to advancing diversity in medicine and science, launched a summer fellowship program designed to do just that.
Seven Weill Cornell Medicine faculty members leading multi-institutional research teams were awarded grants from The Starr Foundation's 12th Starr Cancer Consortium Grant Competition to fund their innovative cancer research projects.
As brain disorders such as Alzheimer’s disease, autism and depression increase in frequency, the synergistic fields of neurology and psychiatry may illuminate important clues that can lead to innovative treatments for these conditions.
Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time.
In recognition of its outstanding commitment to diversity and inclusion, Weill Cornell Medicine has been awarded INSIGHT Into Diversity magazine’s 2018 Health Professions Higher Education Excellence in Diversity (HEED) Award.
A dynamic culture of mentorship should be raised to the level of a major strategic priority at academic medical centers to maximize their success, according to new commentary by administrators from Weill Cornell Medicine and the Association of American Medical Colleges.